Limitations, agreements, and source contact

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma · Source last updated 2026-07-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

heidi.roschitzki@etop.ibcsg.org

organization

ETOP IBCSG Partners Foundation

phone

+41 31 511 94 00

title

Dr. Heidi Roschitzki, PhD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice